CIK 1633055
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2023-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Health Care Equipment & Supplies | 26.41% | 5 |
| Unclassified | 26.07% | 5 |
| Technology Hardware & Equipment | 11.55% | 1 |
| Insurance | 10.71% | 3 |
| Health Care Providers & Services | 9.49% | 3 |
| Pharmaceuticals & Biotechnology | 8.25% | 4 |
| Life Sciences Tools & Services | 4.73% | 2 |
| Equity Real Estate Investment Trusts (REITs) | 1.64% | 1 |
| Distributors | 1.17% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | BSX | BOSTON SCIENTIFIC CORP | Health Care | 12.96% |
| 2 | TMO | THERMO FISHER SCIENTIFIC INC. | Information Technology | 11.55% |
| 3 | AXONICS INC | Unclassified | 8.87% | |
| 4 | ELV | Elevance Health, Inc. | Financials | 7.10% |
| 5 | ICLR | ICON PLC | Unclassified | 5.94% |
| 6 | LABORATORY CORP AMER HLDGS | Unclassified | 5.19% | |
| 7 | EHC | Encompass Health Corp | Health Care | 4.92% |
| 8 | PODD | INSULET CORP | Health Care | 4.86% |
| 9 | HOLX | HOLOGIC INC | Unclassified | 4.76% |
| 10 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Health Care | 3.94% |
20/25 names classified · sector 73.9% of weight · industry 73.9% · mkt cap 73.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 73.9% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 63.7% of book weight (15/23 names) · unclassified 36.3%: , ICLR, HOLX, AVTR, KIDS, QDEL, FTRE, ACRS. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | BSXBOSTON SCIENTIFIC CORP | 39,108 | $2M | 13.0% | TRIM −18% |
| 2 | TMOTHERMO FISHER SCIENTIFIC INC | 3,794 | $2M | 11.5% | TRIM −73% |
| 3 | AXONICS INC | 24,871 | $2M | 8.9% | NEW |
| 4 | ELVELEVANCE HEALTH INC FORMERLY | 2,627 | $1M | 7.1% | TRIM −81% |
| 5 | ICLRICON PLC | 3,659 | $1M | 5.9% | NEW |
| 6 | LABORATORY CORP AMER HLDGS | 3,984 | $905,523 | 5.2% | NEW |
| 7 | EHCENCOMPASS HEALTH CORP | 12,870 | $858,686 | 4.9% | NEW |
| 8 | PODDINSULET CORP | 3,906 | $847,524 | 4.9% | TRIM −56% |
| 9 | HOLXHOLOGIC INC | 11,631 | $831,035 | 4.8% | TRIM −34% |
| 10 | ZBHZIMMER BIOMET HOLDINGS INC | 5,646 | $687,118 | 3.9% | TRIM −68% |
| 11 | AVTRAVANTOR INC | 24,598 | $561,572 | 3.2% | TRIM −89% |
| 12 | THCTenet Healthcare Corp. | 7,303 | $551,888 | 3.2% | TRIM −73% |
| 13 | PFEPFIZER INC | 15,790 | $454,594 | 2.6% | NEW |
| 14 | BMRNBIOMARIN PHARMACEUTICAL INC | 4,650 | $448,353 | 2.6% | TRIM −97% |
| 15 | KIDSORTHOPEDIATRICS CORP | 13,428 | $436,544 | 2.5% | TRIM −81% |
| 16 | CITHE CIGNA GROUP | 1,384 | $414,439 | 2.4% | TRIM −77% |
| 17 | QDELQUIDELORTHO CORP | 5,147 | $379,334 | 2.2% | TRIM −81% |
| 18 | COOCOOPER COMPANIES INC | 988 | $373,899 | 2.1% | TRIM −91% |
| 19 | SBRASABRA HEALTH CARE REIT INC | 20,017 | $285,643 | 1.6% | TRIM −90% |
| 20 | AAGILENT TECHNOLOGIES INC | 1,900 | $264,157 | 1.5% | NEW |
| 21 | FTREFORTREA HLDGS INC | 6,988 | $243,881 | 1.4% | NEW |
| 22 | QIAGEN NV | 5,219 | $226,661 | 1.3% | NEW |
| 23 | HUMHUMANA INC | 469 | $214,713 | 1.2% | TRIM −93% |
| 24 | CORCENCORA INC | 990 | $203,326 | 1.2% | TRIM −91% |
| 25 | ACRSACLARIS THERAPEUTICS INC | 148,400 | $155,820 | 0.9% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
